IQVIA Holdings Inc. (NYSE:IQV) Receives $256.50 Average Target Price from Analysts

IQVIA Holdings Inc. (NYSE:IQV) has been assigned a consensus rating of “Moderate Buy” from the twenty analysts that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, sixteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $256.19.

IQV has been the subject of several research reports. Royal Bank of Canada restated an “outperform” rating and set a $270.00 price objective on shares of IQVIA in a research report on Wednesday. TD Cowen reduced their price objective on IQVIA from $270.00 to $255.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Barclays decreased their price objective on IQVIA from $260.00 to $255.00 and set an “overweight” rating on the stock in a research note on Friday, November 1st. Deutsche Bank Aktiengesellschaft reduced their target price on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Finally, Redburn Atlantic assumed coverage on shares of IQVIA in a report on Monday, October 14th. They set a “buy” rating and a $276.00 price target for the company.

Hedge Funds Weigh In On IQVIA

Hedge funds and other institutional investors have recently modified their holdings of the company. Opal Wealth Advisors LLC acquired a new position in IQVIA during the second quarter valued at approximately $27,000. Capital Performance Advisors LLP purchased a new position in shares of IQVIA in the 3rd quarter valued at $27,000. Park Place Capital Corp acquired a new position in shares of IQVIA during the 3rd quarter valued at $28,000. Itau Unibanco Holding S.A. purchased a new stake in IQVIA during the 2nd quarter worth $29,000. Finally, International Assets Investment Management LLC acquired a new stake in IQVIA in the 2nd quarter valued at $32,000. 89.62% of the stock is owned by institutional investors and hedge funds.

IQVIA Stock Performance

Shares of IQV opened at $199.06 on Friday. IQVIA has a 12-month low of $187.62 and a 12-month high of $261.73. The stock has a market cap of $36.13 billion, a P/E ratio of 26.12, a PEG ratio of 2.07 and a beta of 1.49. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The company has a 50-day moving average of $212.24 and a two-hundred day moving average of $224.23.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.